Beginning on June 1, Germany will accept COVAXIN from Bharat Biotech for use in travel

The WHO-listed COVID vaccination COVAXIN from Bharat Biotech has been approved by the German government for use beginning on June 1 in travel to India, according to Walter J Lindner, the German ambassador to India. In November of last year, the World Health Organization (WHO) added COVAXIN to its...

BHARAT BIOTECH TO SELL COVAXIN IN CANADA WITH THE HELP OF OCUGEN

Highlights

• The two companies have already signed an agreement to sell Covaxin in the United States

Indian biotechnology company Bharat Biotech that had developed Covid-19 vaccine Covaxin is now planning to sell it in the country of Canada with Bharat Biotech with the he...

OCUGEN, BHARAT BIOTECH'S AMERICAN PARTNER SUBMITS MASTER FILE ON COVAXIN TO THE US FDA

Highlights

• Ocugen has submitted a "Master File" to the US Food and Drug Administration before seeking an emergency use authorisation (EUA) in the United States

• The Bharat Biotech told the government of India that it has already submitted 90% of document...

BHARAT BIOTECH FILES FOR EMERGENCY USE LISTING FOR COVAXIN

Highlights

• Bharat Biotech told Indian government that the remaining documents are most likely to be submitted by June

• The vaccine developed by the Hyderabad-based company has already received regulatory approval from 11 countries

According to the source...

INDIAN GOVERNMENT FIRMS PREPARE TO MANUFACTURE COVAXIN

HIGHLIGHTS

• Indian Government firms are preparing to manufacture Covaxin.
• Covaxin was first developed with seed strains received from the National Institute of Virology (NIV).
• Phase 3 clinical trial of Covaxin was co-funded by ICMR.
<...

INDIA’S COVAXIN NEUTRALISES 617 VARIANTS OF COVID-19 SAYS DR. ANTHONY FAUCI

Highlights

• COVAXIN has been developed by Bharat Biotech in partnership with National Institute of Virology and the Indian Council of Medical Research

• Dr. Fauci  said "So, despite the real difficulty that we're seeing in India, vaccination could be a...

BHARAT BIOTECH AND CSIR COLLABORATING TO MAKE RAW MATERIAL FOR VACCINES

HIGHLIGHTS

• India is importing adjuvants and other chemicals for vaccine manufacturing.
• Preservatives for vaccines have been imported from Germany.
• Some raw material has also been imported from the USA.

Hyderabad-based Bhar...

BHARAT BIOTECH GETS DCGI APPROVAL TO CONDUCT COVAXIN TEST THROUGH SKIN

Highlights

• According to the reports, the approval from the DCGI is subject to two conditions

• It is stated that if these clinical trials are successful, the vaccine will be available at a cheaper cost

• Union Minister Dr Harsh Vardhan said if everyt...

COVID-19 VACCINE: SERUM INSTITUTE OF INDIA TO BEGIN PHASE 2 TRIALS OF OXFORD VACCINE THIS WEEK

Highlights

• The Serum Institute of India has stated that it has shortlisted 10 centres across the nation to conduct Phase II and Phase III human clinical trials of COVID-19 vaccine developed by the University of Oxford

• On Monday, the national expert group on vacci...

COVID-19 VACCINE: BHARAT BIOTECH'S COVAXIN SAFE, PHASE II TRIALS TO START IN SEPTEMBER

Highlights

• Total 375 volunteers across 12 sites in India have been given two shots of this COVID-19 vaccine

• As per the reports, no adverse effects were observed at any of the site and the phase 2 trails will start in the month of September

• COVAXI...

COVID-19 VACCINE: HUMAN TRIALS OF COVAXIN BEGIN TODAY AT AIIMS DELHI

Highlights

• People ageing between 18 and 55 and with no comorbidities are eligible to volunteer for the clinical trials of COVAXIN

• COVAXIN developed by Hyderabad-based Bharat Biotech along with the ICMR and the NIV were the first to receive an approval from the DC...

COVAXIN: INDIA’S FIRST COVID-19 VACCINE TO BE TESTED ON 375 PEOPLE IN PHASE I

COVAXIN, the first indigenous COVID-19 vaccine from India is all set to start its human trials from next week. Bharat Biotech, a Hyderabad-based company in association with ICMR and NIV, Pune developed a COVID-19 vaccine that got approval from the DCGI to conduct human trials in the last week. As...

ZYDUS CADILA RECEIVE DCGI NOD FOR HUMAN CLINICAL TRIALS FOR COVID-19 VACCINE

Highlights

• Ahmedabad-based Zydus Cadila Healthcare Ltd will complete the Phase I and Phase II Human clinical trials in three months

• According to the data submitted to the DCGI, the vaccine candidate was found successful in terms of safety and immunogenicity

ICMR-BHARAT BIOTECH TO LAUNCH ‘COVAXIN’ BY AUGUST 15

The people of India are hopeful since a company named Bharat Biotech International Limited (BBIL) from Hyderabad is association with the Indian Council of Medical Research (ICMR) got approval from the Drug Controller General of India (DCGI) to conduct Phase I, II Human clinical trials for the COV...

COVID-19 VACCINE: BHARAT BIOTECH'S ‘COVAXIN’ ALL SET FOR PHASE I, II HUMAN TRIALS

Highlights

• COVAXIN has shown extremely positive results in preclinical trials in terms of safety and effective immune responses

• Bharat Biotech is working on the development of the COVID-19 vaccine in association with the ICMR (Indian Council for Medical Research)...

COVID-19 CASES IN INDIA REACH 5.66 LAKH; DEATH TOLL AT 16,893

• Current Total Cases: 566,840

• Total Deaths : 16,893

• Cumulative recoveries : 334,822

• Active cases: 215,125

• Top five states that has the maximum number of cases : 

Maharashtra: Cases 169,883, number of deaths 7...